Benjamin F. McGraw III
InvestorVenture Partner at Sanderling Ventures · Board director at Theravida
About
Executive Chairman and CEO of TheraVida and CEO of Auration Biotech, and managing member of Long Shadows Asset Management. He previously led Valentis as Chairman/CEO, served as Corporate VP of Corporate Development at Allergan, and worked as a fund manager at Carrera Capital Management, having begun his career in pharmaceutical R&D roles at Marion Laboratories and Marion Merrell Dow. He holds BS and Doctor of Pharmacy degrees from the University of Tennessee.
Board director at Theravida
Intro paths
→
In turn, Benjamin can intro founders to Theravida's investors below.
Theravida's investors · 1
Colleagues at Sanderling Ventures
Fred Middleton
Managing Director at Sanderling Ventures
Michael Dixon
Principal at Sanderling Ventures
Paulette Taylor
General Counsel & Principal at Sanderling Ventures
Peter McWilliams
Venture Partner at Sanderling Ventures
Pierre Beauparlant
Venture Partner at Sanderling Ventures
Robert G. McNeil
Founding Partner at Sanderling Ventures
Timothy Mills
Managing Director at Sanderling Ventures
Frequently asked questions
- Who is Benjamin F. McGraw III?
- Executive Chairman and CEO of TheraVida and CEO of Auration Biotech, and managing member of Long Shadows Asset Management. He previously led Valentis as Chairman/CEO, served as Corporate VP of Corporate Development at Allergan, and worked as a fund manager at Carrera Capital Management, having begun his career in pharmaceutical R&D roles at Marion Laboratories and Marion Merrell Dow. He holds BS and Doctor of Pharmacy degrees from the University of Tennessee.
- Where does Benjamin F. McGraw III work?
- Benjamin F. McGraw III is Venture Partner at Sanderling Ventures and Board director at Theravida.